Bacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysis

被引:43
作者
Orito, Y [1 ]
Morita, M [1 ]
Hori, K [1 ]
Unno, H [1 ]
Tanji, Y [1 ]
机构
[1] Tokyo Inst Technol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan
关键词
D O I
10.1007/s00253-003-1522-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To determine the function of the C-terminal region of Bacillus amyloliquefaciens phage endolysin on Pseudomonas aeruginosa lysis, the permeabilization of the outer membrane of P. aeruginosa was analyzed. Glu-15 to His (E15H) and Thr-32 to Glu (T32E) substitutions were introduced into the Bacillus phage endolysin. Neither E15H nor T32E substitution induced enzymatic and antibacterial activities. These two, Glu-15 and Thr-32, were considered to be the active center of the enzyme. The addition of purified E15H and T32E proteins to P. aeruginosa cells induced the release of periplasmic beta-lactamase from the cells, indicating that both proteins enhance permeabilization of the outer membrane. However, the addition of E15H and T32E proteins to P. aeruginosa cells did not induce the release of cytoplasmic ATP from the cells. These results indicate that the antibacterial activity of the endolysin requires both the C-terminal enhancement of the permeabilization of the P. aeruginosa outer membrane and N-terminal enzymatic activity.
引用
收藏
页码:105 / 109
页数:5
相关论文
共 16 条
[1]   OUTER-MEMBRANE PERMEABILITY IN PSEUDOMONAS-AERUGINOSA - COMPARISON OF A WILD-TYPE WITH AN ANTIBIOTIC-SUPERSUSCEPTIBLE MUTANT [J].
ANGUS, BL ;
CAREY, AM ;
CARON, DA ;
KROPINSKI, AMB ;
HANCOCK, REW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (02) :299-309
[2]   CENTA as a chromogenic substrate for studying β-lactamases [J].
Bebrone, C ;
Moali, C ;
Mahy, F ;
Rival, S ;
Docquier, JD ;
Rossolini, GM ;
Fastrez, J ;
Pratt, RF ;
Frère, JM ;
Galleni, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1868-1871
[3]   The non-enzymatic microbicidal activity of lysozymes [J].
Düring, K ;
Porsch, P ;
Mahn, A ;
Brinkmann, O ;
Gieffers, W .
FEBS LETTERS, 1999, 449 (2-3) :93-100
[4]  
Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5
[5]   The role of antimicrobial peptides in animal defenses [J].
Hancock, REW ;
Scott, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :8856-8861
[6]   The bacterial outer membrane as a drug barrier [J].
Hancock, REW .
TRENDS IN MICROBIOLOGY, 1997, 5 (01) :37-42
[7]   Role of membranes in the activities of antimicrobial cationic peptides [J].
Hancock, REW ;
Rozek, A .
FEMS MICROBIOLOGY LETTERS, 2002, 206 (02) :143-149
[8]   Structural basis of the conversion of T4 lysozyme into a transglycosidase by reengineering the active site [J].
Kuroki, R ;
Weaver, LH ;
Matthews, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :8949-8954
[9]   Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase [J].
Loeffler, JM ;
Nelson, D ;
Fischetti, VA .
SCIENCE, 2001, 294 (5549) :2170-2172
[10]   Functional analysis of antibacterial activity of Bacillus amyloliquefaciens phage endolysin against Gram-negative bacteria [J].
Morita, M ;
Tanji, Y ;
Orito, Y ;
Mizoguchi, K ;
Soejima, A ;
Unno, H .
FEBS LETTERS, 2001, 500 (1-2) :56-59